Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Link
http://www.nature.com/articles/4500992.pdf
Reference14 articles.
1. Schelhammer PF, Sharifi R, Block N, Soloway MS, Venner PM, Patterson AL et al. Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advance prostatic carcinoma: final repot of a double blind randomized multicenter trial. Urology 1997; 50: 330–336.
2. Schellhammer PF . An evaluation of bicalutamide in the treatment of prostate cancer. Expert Opin Pharmacother 2002; 3: 1313–1328.
3. Jenkins V, Fallowfield L, Edginton T, Payne H, Hamilton E . Preferences of healthy men for two different endocrine treatment options offered for locally advanced prostate cancer. Curr Med Res Opinion 2005; 21: 1329–1335.
4. Sculpher M, Bryan S, Fry P, de Winter P, Payne H, Emberton M . Patients’ preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ 2004; 328: 382.
5. Louviere J, Hensher D, Swait JD, Adamowicz W . Stated Choice Methods: Analysis and Applications. Cambridge University Press: Cambridge, UK, 2000.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Patient Preferences for Benefit and Risk Associated With High Intensity Focused Ultrasound for the Ablation of Prostate Tissue in Men With Localized Prostate Cancer;Clinical Genitourinary Cancer;2024-08
2. Influence of Solvent Polarity on the Conformer Ratio of Bicalutamide in Saturated Solutions: Insights from NOESY NMR Analysis and Quantum-Chemical Calculations;International Journal of Molecular Sciences;2024-07-28
3. Patient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments;The Oncologist;2023-11-25
4. Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK;The Patient - Patient-Centered Outcomes Research;2023-08-11
5. Eliciting men’s preferences for decision-making relative to treatments of localized prostate cancer with a good or moderate prognosis;World Journal of Urology;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3